At the 2015 AACC Annual Meeting & Clinical Lab Expo, researchers will present findings that a first-of-its-kind smartphone test for chlamydia can detect the disease with high accuracy, which could reduce the prevalence of this sexually transmitted disease (STD) by making chlamydia screening easier and cheaper.
Clinical laboratory tests play a crucial role in making sure patients get appropriate care, yet many small labs and clinics in low resource settings cannot afford the instruments needed to provide these tests. Research on a novel fingerprick test that can perform all common clinical diagnostics could help to expand access to basic medical testing in the developing world, and will be featured at the 2015 AACC Annual Meeting & Clinical Lab Expo.
Researchers have successfully tested two new potential methods for diagnosing and monitoring diabetes in its standard and gestational forms. These findings, presented today at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta, may lead to easier, timelier, and more affordable ways of identifying and treating this chronic disease.
Hair samples can be used to measure the effects of asthma on the cortisol levels of women during pregnancy, according to research presented today at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta. This research also shows that levels of cortisol, a stress-related hormone, tend to be lower among pregnant women with asthma than among pregnant women without the chronic, inflammatory lung disease.
AACC is pleased to announce the recipients of the AACC 2015 Corporate Supporter Awards. Each year, AACC recognizes the companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
Research presented at the 2015 AACC Annual Meeting & Clinical Lab Expo will expand on the studies that led to a fingerprick Ebola test becoming the first and only rapid diagnostic for this disease to receive approval from the World Health Organization (WHO). This test could prove vital to breaking Ebola’s grip on West Africa by identifying suspected Ebola cases within minutes, and enabling healthcare workers to isolate and treat these patients much faster than is currently possible.
The 2015 AACC Annual Meeting & Clinical Lab Expo, the leading annual event for laboratory medicine, will open on Sunday, July 26, in Atlanta, Georgia. This year’s meeting will host more than 400 educational sessions on topics ranging from personalized medicine and infectious diseases to point-of-care and laboratory-developed tests, and will feature more than 200 new cutting edge diagnostic products.
Noting a paradigm shift among consumers who are seeking greater control over their own healthcare, AACC issued a position statement today on direct-to-consumer laboratory testing, which allows people to order medical tests directly from a lab without having to work with their healthcare provider. The statement emphasizes direct-to-consumer test results must be accurate and easily understood—an area where laboratory medicine professionals play a vital role.
Streck will be a sponsor and exhibitor at the AACC Annual Meeting & Clinical Lab Expo. Streck has a number of new products this year; find us at booth #2552 to learn more
As BBI Solutions (BBI) prepare for its 25th consecutive attendance at AACC, visitors to the BBI booth can expect to discover the increasing importance of high quality biological raw materials in driving assay performance and how BBI’s new, innovative products can help achieve this.
The BBI Group (BBI) today announced it has developed in collaboration with the Defence Science and Technology Laboratory (Dstl) and licensed, through technology transfer company Ploughshare Innovations, a rapid test for Ebola. The assay, which is in the process of being verified to allow EUA submission, will be used to test patients suspected of Ebola infection to screen and potentially help with how they are subsequently managed. The test, utilising lateral flow technology, can provide a result in approximately 20 minutes.
Enigma Diagnostics Ltd. (Enigma) and Beijing Leadman Biochemistry Co., Ltd. (Beijing Leadman) (SZSE:300289) signed a joint venture agreement with the principal goal of delivering the Enigma MiniLab molecular diagnostic Point-of-Care platform into the Chinese health care market to support its growing diagnostic needs.
Parker Hannifin Corporation announces the release of the R9 Diaphragm Rocker Isolation Liquid Valve, a family of 9 mm valves that improves performance of Clinical Diagnostic, Analytical Chemistry and Agent Detection systems requiring precision fluid control
— Visiun, Inc., the leader in performance analytics for the laboratory, announced today that the Compass Group has awarded them a sole source agreement for business intelligence software for their 26 health systems, encompassing over 380 hospitals nationwide. Following a vendor evaluation process, the Compass Group selected Visiun’s feature-rich Performance Insight™.
Visiun, Inc., the leader in performance analytics for the laboratory, is celebrating 5 years of proudly supporting the laboratory community and will be showcasing their feature-rich Performance Insight™ at the AACC Clinical Lab Expo, taking place July 28-30, at the Georgia World Congress Center in Atlanta, Georgia
Beckman Coulter will be showing the Aquios CL Flow Cytometer and setting up one-to-one demonstrations at their Booth #521 during the 2015 AACC Annual Meeting & Clinical Lab Expo to be held in Atlanta, Georgia, July 28-30, 2015.
Marker Test Diagnostics, Inc., a leading international supplier to the drug testing industry, announced today that the company has completed a corporate relocation for its U.S. headquarters from Leesburg, Va. to Chandler, Az.
The CrAg Lateral Flow Assay (LFA) a novel, rapid diagnostic test, is playing a crucial role in saving lives all over the world. The CrAg LFA tests for an infection called Cryptococcosis, which kills over 600,000 people every year, primarily in HIV/AIDS patients. Because of the ease-of-use and room temperature storage, the CrAg LFA, developed by IMMY, is the only test capable of bridging the gap between this disease and the life-saving medicine these patients need.
Festo displays at AACC 2015 at the World Congress Center in Atlanta, July 28-30, its high-speed, precise, automated handling system for clinical laboratory applications – the EXCM mini H-gantry. Festo also presents a number of systems designed to automate clinical laboratory processes.
Marker Test Diagnostics, Inc., a leading international supplier to the drug testing industry, has secured its first agreement to distribute its UR Code urine marker product in the U.S. with Elithea Sciences, a leading provider of drug confirmation testing, toxicology and analytical services.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right